Total Payments
$2,655
2024 Payments
$59.73
Companies
14
Transactions
42
Medicare Patients
1,280
Medicare Billing
$122,260
Payment Breakdown by Category
Food & Beverage$2,513 (94.7%)
Education$141.73 (5.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,513 | 40 | 94.7% |
| Education | $141.73 | 2 | 5.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,278 | 19 | $0 (2022) |
| VYNE Pharmaceuticals Inc. | $265.22 | 2 | $0 (2021) |
| Incyte Corporation | $206.87 | 4 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $184.72 | 2 | $0 (2022) |
| Lilly USA, LLC | $177.79 | 4 | $0 (2022) |
| GENZYME CORPORATION | $143.83 | 2 | $0 (2021) |
| Ortho Dermatologics, a division of Bausch Health US, LLC | $138.65 | 2 | $0 (2022) |
| LEO Pharma Inc. | $66.63 | 1 | $0 (2022) |
| PFIZER INC. | $45.96 | 1 | $0 (2022) |
| UCB, Inc. | $41.25 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $59.73 | 1 | Incyte Corporation ($59.73) |
| 2023 | $52.08 | 1 | Incyte Corporation ($52.08) |
| 2022 | $1,209 | 17 | ABBVIE INC. ($501.34) |
| 2021 | $1,016 | 15 | AbbVie Inc. ($515.48) |
| 2020 | $302.66 | 7 | AbbVie Inc. ($261.57) |
| 2019 | $15.50 | 1 | Merck Sharp & Dohme Corporation ($15.50) |
All Payment Transactions
42 individual payment records from CMS Open Payments — Page 2 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/15/2021 | VYNE Pharmaceuticals Inc. | AMZEEQ (Drug) | Food and Beverage | In-kind items and services | $118.06 | General |
| Category: Treatment of ACNE Vulgaris | ||||||
| 05/24/2021 | UCB, Inc. | — | Food and Beverage | In-kind items and services | $41.25 | General |
| 05/21/2021 | AbbVie Inc. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $23.60 | General |
| Category: IMMUNOLOGY | ||||||
| 04/09/2021 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $20.84 | General |
| Category: Immunology | ||||||
| 03/19/2021 | AbbVie Inc. | SKYRIZI (Biological), HUMIRA | Food and Beverage | In-kind items and services | $20.48 | General |
| Category: IMMUNOLOGY | ||||||
| 03/12/2021 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $28.88 | General |
| Category: Immunology | ||||||
| 02/16/2021 | AbbVie Inc. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $26.82 | General |
| Category: IMMUNOLOGY | ||||||
| 01/26/2021 | AbbVie Inc. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $26.11 | General |
| Category: IMMUNOLOGY | ||||||
| 01/22/2021 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $20.85 | General |
| Category: Immunology | ||||||
| 11/18/2020 | AbbVie Inc. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $48.52 | General |
| Category: IMMUNOLOGY | ||||||
| 10/30/2020 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $20.20 | General |
| Category: Immunology | ||||||
| 10/22/2020 | AbbVie Inc. | SKYRIZI (Biological), HUMIRA | Food and Beverage | In-kind items and services | $35.02 | General |
| Category: IMMUNOLOGY | ||||||
| 10/06/2020 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $20.89 | General |
| Category: Immunology | ||||||
| 09/24/2020 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $37.26 | General |
| Category: IMMUNOLOGY | ||||||
| 02/26/2020 | AbbVie Inc. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $72.03 | General |
| Category: IMMUNOLOGY | ||||||
| 01/22/2020 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $68.74 | General |
| Category: IMMUNOLOGY | ||||||
| 02/08/2019 | Merck Sharp & Dohme Corporation | GARDASIL9 (Biological) | Food and Beverage | In-kind items and services | $15.50 | General |
| Category: VACCINE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 1,109 | 1,897 | $381,307 | $107,458 |
| 2022 | 9 | 171 | 202 | $48,873 | $14,802 |
Total Patients
1,280
Total Services
2,099
Medicare Billing
$122,260
Procedure Codes
22
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 207 | 279 | $77,562 | $28,099 | 36.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 119 | 119 | $50,456 | $15,196 | 30.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 128 | 162 | $30,618 | $10,672 | 34.9% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 170 | 224 | $57,344 | $9,721 | 17.0% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 84 | 99 | $28,809 | $9,001 | 31.2% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 30 | 31 | $24,831 | $8,244 | 33.2% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 94 | 111 | $39,474 | $8,226 | 20.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 81 | 81 | $22,518 | $7,053 | 31.3% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 122 | 687 | $18,549 | $3,934 | 21.2% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 23 | 24 | $15,888 | $2,672 | 16.8% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 26 | 55 | $6,325 | $2,362 | 37.3% |
| 11301 | Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm | Office | 2023 | 14 | 14 | $4,368 | $1,239 | 28.4% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 11 | 11 | $4,565 | $1,041 | 22.8% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 31 | 32 | $11,380 | $2,734 | 24.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 30 | 30 | $8,340 | $2,539 | 30.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 16 | 16 | $6,784 | $2,197 | 32.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 18 | 19 | $5,282 | $2,126 | 40.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 21 | 24 | $4,536 | $1,907 | 42.0% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 12 | 12 | $3,492 | $1,210 | 34.7% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 19 | 22 | $5,632 | $1,038 | 18.4% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 13 | 13 | $2,509 | $836.16 | 33.3% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 11 | 34 | $918.00 | $214.55 | 23.4% |
About Laura Walsh, MD, PHD
Laura Walsh, MD, PHD is a Dermatology healthcare provider based in Renton, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/29/2018. The National Provider Identifier (NPI) number assigned to this provider is 1043715006.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Laura Walsh, MD, PHD has received a total of $2,655 in payments from pharmaceutical and medical device companies, with $59.73 received in 2024. These payments were reported across 42 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($2,513).
As a Medicare-enrolled provider, Walsh has provided services to 1,280 Medicare beneficiaries, totaling 2,099 services with total Medicare billing of $122,260. Data is available for 2 years (2022–2023), covering 22 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Other Specialties Dermatology
- Location Renton, WA
- Active Since 03/29/2018
- Last Updated 11/11/2022
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1043715006
Products in Payments
- SKYRIZI (Biological) $517.56
- HUMIRA (Biological) $396.78
- AMZEEQ (Drug) $265.22
- RINVOQ (Biological) $239.05
- OPZELURA (Drug) $206.87
- DUPIXENT (Biological) $204.92
- TALTZ (Drug) $70.62
- SILIQ (Drug) $69.65
- ARAZLO (Drug) $69.00
- ADBRY (Biological) $66.63
- SPEVIGO (Drug) $39.48
- CLODERM (Drug) $30.00
- TREMFYA (Drug) $20.84
- GARDASIL9 (Biological) $15.50
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Renton
Dr. Marcus Tan, Md, Faad, Frcpc, MD, FAAD, FRCPC
Dermatology — Payments: $7,436
Dermatology $7,436
Dr. Jodie Sasaki, M.d., M.s, M.D., M.S
Dermatology — Payments: $5,741
Dermatology $5,741
Zixiao Wang
Dermatology — Payments: $680.25
Dermatology $680.25
Dr. Craig Fujisaki, M.d, M.D
Dermatology — Payments: $615.06
Dermatology $615.06
Brian Kumasaka, Md, MD
Dermatology — Payments: $455.36
Dermatology $455.36
Kevin Luk
Dermatology — Payments: $146.12
Dermatology $146.12